Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konjeti R Sekhar

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Free Radical Biology & Medicine|May 16, 2015
Nrf2 promotes survival following exposure to ionizing radiationKonjeti R Sekhar, Michael L Freeman
Cancer Research|March 6, 2023
Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer TreatmentKonjeti R Sekhar, Michael L Freeman
World Journal of Surgery|October 4, 2022
Ferroptosis Inducers in Thyroid CancerKonjeti R Sekhar, Sriram Cyr, Naira Baregamian
Toxicology and Applied Pharmacology|June 30, 2009
Cysteine-based regulation of the CUL3 adaptor protein Keap1Konjeti R Sekhar, Girish Rachakonda, Michael L Freeman
Bioorganic & Medicinal Chemistry Letters|September 10, 2010
Radiosensitization of cancer cells by hydroxychalconesRory Pruitt, Nidhish Sasi, Michael L Freeman, et al.
Radiation Research|May 26, 2018
The Role of Nrf2 in the Response to Normal Tissue Radiation InjuryBrent D Cameron, Konjeti R Sekhar, Maxwell Ofori, et al.
The Journal of Biological Chemistry|June 30, 2005
Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activationFei Hong, Konjeti R Sekhar, Michael L Freeman, et al.
Handbook of Experimental Pharmacology|September 23, 2010
Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compoundsSharron H Francis, Konjeti R Sekhar, Hengming Ke, et al.
Plos One|April 2, 2019
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathwayKonjeti R Sekhar, Jian Wang, Michael L Freeman, et al.
Bioorganic & Medicinal Chemistry|April 30, 2015
Development and validation of a novel assay to identify radiosensitizers that target nucleophosmin 1Narsimha R Penthala, Peter A Crooks, Michael L Freeman, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Free Radical Biology & Medicine|May 16, 2015
Nrf2 promotes survival following exposure to ionizing radiationKonjeti R Sekhar, Michael L Freeman
Cancer Research|March 6, 2023
Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer TreatmentKonjeti R Sekhar, Michael L Freeman
World Journal of Surgery|October 4, 2022
Ferroptosis Inducers in Thyroid CancerKonjeti R Sekhar, Sriram Cyr, Naira Baregamian
Toxicology and Applied Pharmacology|June 30, 2009
Cysteine-based regulation of the CUL3 adaptor protein Keap1Konjeti R Sekhar, Girish Rachakonda, Michael L Freeman
Bioorganic & Medicinal Chemistry Letters|September 10, 2010
Radiosensitization of cancer cells by hydroxychalconesRory Pruitt, Nidhish Sasi, Michael L Freeman, et al.
Radiation Research|May 26, 2018
The Role of Nrf2 in the Response to Normal Tissue Radiation InjuryBrent D Cameron, Konjeti R Sekhar, Maxwell Ofori, et al.
The Journal of Biological Chemistry|June 30, 2005
Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activationFei Hong, Konjeti R Sekhar, Michael L Freeman, et al.
Handbook of Experimental Pharmacology|September 23, 2010
Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compoundsSharron H Francis, Konjeti R Sekhar, Hengming Ke, et al.
Plos One|April 2, 2019
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathwayKonjeti R Sekhar, Jian Wang, Michael L Freeman, et al.
Bioorganic & Medicinal Chemistry|April 30, 2015
Development and validation of a novel assay to identify radiosensitizers that target nucleophosmin 1Narsimha R Penthala, Peter A Crooks, Michael L Freeman, et al.
Pageof 5